Megumi Jinguji Selected Research

Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)

3/2024	Machine learning approach using 18F-FDG-PET-radiomic features and the visibility of right ventricle 18F-FDG uptake for predicting clinical events in patients with cardiac sarcoidosis.
8/2023	Clinical application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography radiomics-based machine learning analyses in the field of oncology.
1/2022	Machine learning based evaluation of clinical and pretreatment 18F-FDG-PET/CT radiomic features to predict prognosis of cervical cancer patients.
1/2021	Case Report: 18F-FDG PET-CT for Diagnosing Prosthetic Device-Related Infection in an Infant With CHD.
2/2019	18F-FDG-PET/CT features of primary tumours for predicting the risk of recurrence in thyroid cancer after total thyroidectomy: potential usefulness of combination of the SUV-related, volumetric, and heterogeneous texture parameters.
12/2017	A pilot study for texture analysis of 18F-FDG and 18F-FLT-PET/CT to predict tumor recurrence of patients with colorectal cancer who received surgery.
8/2017	Bilateral Tibial Osteofibrous Dysplasia on 18F-FDG PET/CT.
2/2017	Texture analysis of 18F-FDG PET/CT to predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy.
1/2017	Current clinical status of 18F-FLT PET or PET/CT in digestive and abdominal organ oncology.
5/2016	Increased 18F-FDG Uptake in the Spleen and Multiple Lymph Nodes in Dengue Fever.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Megumi Jinguji Research Topics

Disease

11	Neoplasms (Cancer) 10/2023 - 01/2006
8	Pheochromocytoma 04/2023 - 01/2014
5	Thyroid Neoplasms (Thyroid Cancer) 07/2022 - 06/2013
5	Paraganglioma (Paragangliomas) 03/2022 - 01/2014
3	Graves Disease (Basedow Disease) 07/2017 - 06/2005
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2015 - 01/2014
2	Neoplasm Metastasis (Metastasis) 07/2022 - 06/2013
2	Hypoxia (Hypoxemia) 12/2020 - 12/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 04/2016
2	Colorectal Neoplasms (Colorectal Cancer) 12/2017 - 12/2014
2	Lymphatic Metastasis 04/2016 - 01/2006
2	Neuroblastoma 07/2015 - 02/2015
1	Sarcoidosis (Schaumann Disease) 03/2024
1	Left Ventricular Dysfunction 04/2023
1	Hypopharyngeal Neoplasms 01/2023
1	Papillary Thyroid Cancer 07/2022
1	Mediastinal Cyst 07/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Endometrial Neoplasms (Endometrial Cancer) 10/2021
1	Carcinoma (Carcinomatosis) 09/2021
1	Congenital Heart Defects (Congenital Heart Defect) 01/2021
1	Bacteremia 01/2021
1	Infections 01/2021
1	Cushing Syndrome 12/2020
1	Hyperaldosteronism (Conn Syndrome) 12/2020
1	Osteofibrous Dysplasia 08/2017
1	Thymus Hyperplasia 07/2017
1	Esophageal Neoplasms (Esophageal Cancer) 02/2017
1	Dengue (Dengue Fever) 05/2016
1	Papilloma (Papillomatosis) 11/2015
1	Intraductal Papilloma 11/2015
1	Angiomyolipoma 10/2014
1	Hyperthyroidism 06/2005
1	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 03/2003

Drug/Important Bio-Agent (IBA)

12	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2024 - 11/2015
8	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 06/2013
6	3-Iodobenzylguanidine (Iobenguane)IBA 04/2023 - 01/2014
3	Thyroid HormonesIBA 07/2017 - 06/2005
2	fluoroazomycin arabinosideIBA 12/2020 - 12/2020
2	alovudineIBA 12/2017 - 01/2017
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 03/2024
1	sodium-iodide symporter (sodium iodide symporter)IBA 07/2022
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 09/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	AdosterolIBA 12/2020
1	methylallyl trisulfide (MATS)IBA 12/2017
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2016
1	HexokinaseIBA 11/2015
1	thymidine kinase 1IBA 12/2014
1	Ethanol (Ethyl Alcohol)IBA 10/2014
1	Therapeutic UsesIBA 01/2014
1	Iodine-131IBA 01/2014
1	FluorineIBA 06/2013
1	Hormones (Hormone)IBA 01/2006
1	DiureticsIBA 03/2003

Therapy/Procedure

13	Therapeutics 07/2022 - 06/2005
3	Radiotherapy 07/2015 - 01/2014
2	Thyroidectomy 07/2022 - 02/2019
1	Chemoradiotherapy 02/2017
1	Oral Administration 04/2016